Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
Covid-19 treatment rates at private hospitals under radar in AP Adity Saha26 Jan 2022 9:00 AM ISTVijayawada: With surge in Covid-19 cases in Andhra Pradesh, private hospitals and diagnostic centers have fallen under health wing's radar in order to...
Gilead Sciences Remdesivir gets USFDA nod to treat non-hospitalized COVID patients Ruchika Sharma25 Jan 2022 1:48 PM ISTFoster City: Gilead Sciences, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has granted expedited approval of a...
USFDA halts use of Regeneron, Lilly Covid-19 antibody treatments Ruchika Sharma25 Jan 2022 11:52 AM ISTNew Delhi: The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli...
Expedite progress under ECRP-II to strengthen health infrastructure: Mandaviya MD Bureau25 Jan 2022 9:45 AM ISTUnion Health Minister Mansukh Mandaviya has asked the states to review and expedite implementation of activities under ECRP II package for...
Partial or unvaccinated account for 60 percent COVID deaths in third wave: Max study Medical Dialogues Bureau24 Jan 2022 9:30 AM ISTThe study by Max Healthcare said the deaths reported were largely among those aged over 70 and those suffering from multiple comorbidities such as...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 9:00 AM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
USFDA adds all blood sample collection tubes to medical device shortage list Dr. Divya Colin23 Jan 2022 11:15 AM ISTNew Delhi: The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection...
Australia gets 5th approved Covid-19 vaccine in Novavax Dr. Divya Colin23 Jan 2022 10:45 AM ISTThe Novavax vaccine will be available to unvaccinated Australians aged 18 years and older but will not be used as a booster for the 95% of the...
Laurus Labs inks pact with MPP to manufacture molnupiravir Medical Dialogues Bureau22 Jan 2022 3:52 PM ISTNew Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19...
Biophore India gets MPP licence to market molnupiravir Dr. Divya Colin22 Jan 2022 3:14 PM ISTNew Delhi: Biophore India Pharmaceuticals on Thursday said it has received licences from Medicines Patent Pool (MPP) on behalf of originator company...
Moderna to come up with combined COVID, flu booster by 2023 MD Bureau21 Jan 2022 10:00 AM ISTWashington: US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at...
